A detailed history of Mediolanum International Funds LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Mediolanum International Funds LTD holds 59,902 shares of NBIX stock, worth $7.52 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
59,902
Previous 46,093 29.96%
Holding current value
$7.52 Million
Previous $5.78 Billion 19.06%
% of portfolio
0.1%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$114.58 - $153.15 $1.58 Million - $2.11 Million
13,809 Added 29.96%
59,902 $6.88 Billion
Q2 2024

Aug 13, 2024

BUY
$130.86 - $143.19 $4.75 Million - $5.2 Million
36,289 Added 370.14%
46,093 $5.78 Billion
Q1 2024

May 03, 2024

BUY
$130.4 - $143.74 $1.28 Million - $1.41 Million
9,804 New
9,804 $1.35 Billion

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Mediolanum International Funds LTD Portfolio

Follow Mediolanum International Funds LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mediolanum International Funds LTD, based on Form 13F filings with the SEC.

News

Stay updated on Mediolanum International Funds LTD with notifications on news.